EUVIMEDEUVIMED entdecken
Validierungsstudie

Stool-based Xpert testing for diagnosis of TB in children and critically ill adults

W Mwanza, M Lutinala, K Mundia, E Klinkenberg, P de Haas, M Kabaso, K Zimba, C Chabala, B Tambatamba, M Angel, P Lungu, K Lishimpi

The International Journal of Tuberculosis and Lung Disease · 2025

DOI: 10.5588/ijtld.24.0349 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2025. Verfasst von W Mwanza und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Health, Lusaka, Zambia;, USAID-STAR Project, Washington DC, USA. Hauptthemen laut MEDLINE: Feces, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND

We describe our approach and experience with the routine implementation of stool-based Xpert MTB/RIF Ultra (Xpert) testing for the diagnosis of childhood TB in Zambia.





METHODS

We conducted a method validation and subsequently introduced stool as an alternative sample for routine Xpert testing for children and critically ill adults. We reviewed the impact of stool-based Xpert testing during the first 18 months of routine implementation.





RESULTS

The method validation showed 98.0% (95% CI 92.9–99.4) agreement between Xpert results on sputum/gastric aspirate (GA) and stool specimens. During 18 months of routine implementation, 16,210 stool samples were tested, yielding 157 TB cases in children, including five rifampicin (RIF) resistant cases, and 45 cases in critically ill adults. In children aged 0–4 years, 10,288 stool samples were tested compared to 2,459 GA samples in the same period. Childhood TB notifications and the bacteriological confirmation rate increased by 30% and 53%, respectively, in 2021 compared to 2020.





CONCLUSION

The routine implementation of stool testing provided access to Xpert testing for children who could not produce sputum or have GA collected, contributing to increased bacteriological confirmation of TB in children. For critically ill adults with difficulty expectorating sputum, it facilitated a rapid test result.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesTuberculosisHumansCritical IllnessChild, PreschoolInfantAdultChildZambiaSputumInfant, NewbornAdolescentMaleFemaleMycobacterium tuberculosisYoung AdultRifampin

Substanzen

Rifampin

Autor:innen und Institutionen

  • Ministry of Health, Lusaka, Zambia;, USAID-STAR Project, Washington DC, USA.
  • PATH, Lusaka, Zambia.
  • Ministry of Health, Lusaka, Zambia.
  • Independent Consultant, Connect TB, The Hague, the Netherlands;, Department of Global Health, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • KNCV Tuberculosis Foundation, the Hague, the Netherlands.
  • USAID, Lusaka, Zambia.

Zitieren

APA

Mwanza, W., Lutinala, M., Mundia, K., Klinkenberg, E., de Haas, P., Kabaso, M., Zimba, K., Chabala, C., Tambatamba, B., Angel, M., Lungu, P., & Lishimpi, K. (2025). Stool-based Xpert testing for diagnosis of TB in children and critically ill adults. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.24.0349

Vancouver

Mwanza W, Lutinala M, Mundia K, Klinkenberg E, de Haas P, Kabaso M, et al. Stool-based Xpert testing for diagnosis of TB in children and critically ill adults. The International Journal of Tuberculosis and Lung Disease. 2025. doi:10.5588/ijtld.24.0349

BibTeX
@article{Mwanza2025,
  author = {Mwanza, W and Lutinala, M and Mundia, K and Klinkenberg, E and de Haas, P and Kabaso, M and Zimba, K and Chabala, C and Tambatamba, B and Angel, M and Lungu, P and Lishimpi, K},
  title = {Stool-based Xpert testing for diagnosis of TB in children and critically ill adults},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2025},
  doi = {10.5588/ijtld.24.0349}
}
Kostenlos starten →